Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

Viral Mutations

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Emerging Piperazine Derivatives: Synthesis, Characterization, Biological Evaluation, Molecular Docking, and ADMET In silico Studies.

Drug metabolism and bioanalysis·2026

Same author

From gastric to neuroprotection: pantoprazole mitigates epilepsy via TrkB/BDNF and KCC2 modulation.

Naunyn-Schmiedeberg's archives of pharmacology·2026

Same author

A Review on the Pathophysiology of Alzheimer's Disease.

Current protein & peptide science·2025

Same author

Pathological Insights into Neurodegenerative and Neurodevelopmental Disorders: Perspectives for the Development of Novel Treatment Approaches.

CNS & neurological disorders drug targets·2025

Same author

Molecular mechanisms and emerging therapeutics in pulmonary fibrosis: A recent update.

European journal of pharmacology·2025

Same author

Bruton's Tyrosine Kinase Inhibitors: A Versatile Therapeutic Approach for Cancer, Autoimmune Disorders, GVHD and COVID-19.

Mini reviews in medicinal chemistry·2025

Search research articles

Related Experiment Video

Updated: Jan 11, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

A Comprehensive Review on Human Metapneumovirus.

Uma Agarwal¹, Swati Paliwal¹, Rajiv Kumar Tonk¹

¹Department of Pharmaceutical Chemistry, Delhi Pharmaceutical Sciences & Research University, Delhi, 110017, India.

Current Gene Therapy

|November 9, 2025

Summary

Human metapneumovirus (HMPV) causes respiratory illness but is less severe than HRSV and doesn't show seasonal trends. Co-infections and kidney injury risks need further study.

Keywords:

Human metapneumovirus communicable disease.respiratory infection respiratory virus vaccine development

More Related Videos

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Related Experiment Videos

Last Updated: Jan 11, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Area of Science:

Virology
Public Health
Infectious Diseases

Background:

Human metapneumovirus (HMPV) is a respiratory virus with cold-like symptoms, transmitted via droplets and surfaces.
It poses a significant threat to vulnerable populations, especially young children, and contributes to infant mortality.
HMPV was first identified in 2001, highlighting ongoing research into its impact.

Purpose of the Study:

To consolidate vital information on human metapneumovirus (HMPV) and its effects on respiratory illnesses.
To advance the understanding of HMPV-related diseases and inform public health responses.
To identify knowledge gaps and guide future research and interventions for HMPV.

Main Methods:

A comprehensive literature search was conducted using major databases up to May 2025.
Studies were selected based on extensive prior research concerning human metapneumovirus globally.
The review synthesized existing data on HMPV epidemiology, clinical features, and outcomes.

Main Results:

HMPV exhibits gradual mutations, leading to new strains with moderate variations in clinical presentation.
Unlike other respiratory viruses, HMPV shows no significant seasonal incidence patterns.
HMPV infections are generally less severe than HRSV, but co-infections in children increase severity and risk of acute kidney injury (AKI).

Conclusions:

HMPV's evolutionary trajectory limits pandemic potential, but co-infections and AKI risk necessitate monitoring and research.
Pre-existing immunity may mitigate HMPV effects, suggesting potential for vaccines or immune-boosting strategies.
Further research and routine HMPV testing are crucial for developing effective treatments and prevention strategies, especially for at-risk groups.